GS0401: Custom production of DNA encoded compounds and libraries for others
DM0000: The mark consists of the stylized words X-CHEM above the stylized words TAKE THE LEAD. DRIVE DISCOVERY. Above and to the right of the letter M there are a stylized pentagon, square and hexagon.
GS0051: biological, chemical and biochemical preparations for the treatment of cancer, cardiovascular, gastrointestinal, musculoskeletal, infectious disease, endocrine, metabolic, central nervous system disorders, respiratory, infectious disease and blood disorders; chemico-pharmaceutical preparations for use in treatment of cancer, cardiovascular, gastrointestinal, musculoskeletal, infectious disease, endocrine, metabolic, central nervous system disorders, respiratory, infectious disease and blood disorders
CC0000: Color is not claimed as a feature of the mark.
GS0011: Chemical, biochemical and biological substances and preparations for use in industry and science; chemical, biochemical and biological substances and preparations for use in drug research, discovery and development; DNA encoded chemical compounds for use in biochemical research and in drug research, discovery and development; DNA encoded chemical preparations for use in biochemical research and in drug research, discovery and development; DNA encoded compounds for use in industry and science; Biological, chemical, biochemical, and DNA-encoded preparations for use in science and medical research
GS0451: Licensing of intellectual property rights, namely, rights in compounds developed, created or included in DNA encoded compound libraries
GS0421: Scientific and technological research services for pharmaceutical and medical purposes; research and development services related to drug discovery; scientific research and product development services in the pharmaceutical, biotechnology and medical fields; research and development services related to screening, synthesis and analysis of DNA encoded compounds and libraries; development of DNA encoded compounds and libraries; chemical and biological research services related to drug discovery and development; chemist and chemical research services related to drug discovery and development; research and development services utilizing artificial intelligence and machine learning in the field of drug discovery; research and development involving small molecule drug discovery; providing temporary use of non-downloadable computer software, and software as a service (SAAS) services, for use in drug research, discovery and development
Case File Event Statements
11/7/2023 - a year ago
28 - NOTICE OF REGISTRATION CONFIRMATION EMAILEDType:NRCC
11/7/2023 - a year ago
27 - REGISTERED-PRINCIPAL REGISTERType:R.PR
11/6/2023 - a year ago
26 - ASSIGNED TO EXAMINERType:DOCK
8/22/2023 - a year ago
25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
8/22/2023 - a year ago
24 - PUBLISHED FOR OPPOSITIONType:PUBO
8/2/2023 - a year ago
23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
7/20/2023 - a year ago
22 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
7/20/2023 - a year ago
21 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
7/20/2023 - a year ago
20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
7/20/2023 - a year ago
19 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
7/20/2023 - a year ago
18 - EXAMINERS AMENDMENT -WRITTENType:CNEA
6/20/2023 - a year ago
17 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINSType:EWAF
6/20/2023 - a year ago
16 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA